A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Titel:
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Auteur:
Wakelee, Heather A. Gettinger, Scott Engelman, Jeffrey Jänne, Pasi A. West, Howard Subramaniam, Deepa S. Leach, Joseph Wax, Michael Yaron, Yifah Miles, Dale R. Lara, Primo N.